General
Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run
Canada NewsWire VANCOUVER, BC, March 31, 2021 /CNW/ – Willow Biosciences Inc. (” Willow ” or the ” Company “) (TSX: WLLW) (OTCQX:
Global
Health Canada Approves REBLOZYL® (luspatercept), New Class of Treatment for Adult Patients Living with Myelodysplastic Syndromes
Canada NewsWire REBLOZYL®, an erythroid maturation agent, is the first and only of its kind approved for use inCanada
Leaders
Eisai Awarded The New Diversity Management Selection 100
TOKYO, Mar 22, 2021 – (JCN Newswire) – Eisai Co., Ltd. announced today that it was selected as one of
Technology
MindMed Reaches Agreement to Acquire HealthMode
Canada NewsWire Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine
